An individual approach
The Institute's specialists study each case and develop an individual protocol that takes the specifics of the disease into account.
The basis of individual protocols
Preclinical studies of the drug have been completed in full. Protocols for a wide range of cancer sites were developed during clinical trials. On this basis, the Institute's specialists develop a protocol for each patient, taking into account the diagnosis, the stage of the disease, medical history and general condition.
Strategies for developing personalised programmes
- Path 1 · Oncology and gerontology
Individual programme
The Institute's specialists review your case and develop an individual protocol. This suits you if you are ready to start without a preliminary test.
- Path 2 · Oncology
Choosing therapy by individual effectiveness
Determining how sensitive the tumour cells are to the protocol makes it possible to assess its expected effect before therapy begins.
How to apply
- 01
Request
Fill in a short form: how to contact you and what you are writing about. Medical documents can be shared at the next step.
- 02
Reply from the team
The Institute's team reviews your request and replies by email or via a messenger of your choice.
- 03
Medical documents
To select a protocol, the specialists need your medical documents. The team explains exactly which ones are needed and how to share them securely.
- 04
Individual protocol
The Institute's specialists develop a protocol taking into account the diagnosis, the stage of the disease, medical history and general condition, and set out the terms of participation, including the cost.
- 05
Your decision
You discuss the protocol and terms with your treating physician. The decision to start the programme is made by you and your doctor.
Sending a request is not an order for a service or a study, does not create a doctor–patient relationship and does not replace medical care.
Testing the drug on the patient's tumour cells
Laboratory testing of treatment effectiveness on a tumour sample — before the course of therapy begins.
A team of experts will choose the appropriate study format and a specialised laboratory.
Organoids
Three-dimensional models are grown from tumour cells and used to test the drug's effect. This approach makes it possible to predict the body's response to therapy with high accuracy. The study takes two to three months and provides a detailed basis for choosing the optimal treatment regimen.
The specialised laboratory is chosen individually, based on the specifics of the clinical task and your location.
Our experts are ready to discuss the detailed terms of cooperation and how the project will be carried out in a personal consultation.
The results of a laboratory study are not a diagnosis. They should be discussed with your treating physician.
Individual working format
Our team develops programmes entirely on the basis of its own technologies. Because each project requires extensive scientific work and unique resources, the Institute runs a strictly limited number of programmes at any one time.
We consider each new request individually: once our specialists have made an initial assessment of the medical records, we contact the patient to discuss whether further cooperation is possible and on what terms.
Send a request
Choose what you are writing about. Documents can be shared later: after the first reply, the team will tell you which ones are needed and how to send them securely.